Hudson Executive Capital LP Diversified Active

CIK: 0001652522 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $217,580 (100.0% shares, 0.0% debt)

Holdings (7)

EGRX EAGLE PHARMACEUTICALS INC 34.5%

Value ($000) $74,993 Shares 950,600 Est. Cost $46.48 Unrealized +75.9%

— CIT GROUP INC 24.0%

Value ($000) $52,151 Shares 1,070,857 Est. Cost $37.71 Unrealized —

ATRC ATRICURE INC 20.7%

Value ($000) $44,984 Shares 1,855,000 Est. Cost $17.10 Unrealized +24.3%

— CORINDUS VASCULAR ROBOTICS I 9.7%

Value ($000) $21,085 Shares 11,336,154 Est. Cost $1.31 Unrealized —

— ACORDA THERAPEUTICS INC 7.0%

Value ($000) $15,230 Shares 773,090 Est. Cost $19.70 Unrealized —

— MAGELLAN HEALTH INC 3.3%

Value ($000) $7,195 Shares 98,700 Est. Cost $75.25 Unrealized —

— MERIDIAN BIOSCIENCE INC 0.9%

Value ($000) $1,942 Shares 123,300 Est. Cost $15.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
EGRX	EAGLE PHARMACEUTICALS INC	950,600	$74,993	34.5%	$46.48	+75.9%	COM	269796108
—	CIT GROUP INC	1,070,857	$52,151	24.0%	$37.71	—	COM NEW	125581801
ATRC	ATRICURE INC	1,855,000	$44,984	20.7%	$17.10	+24.3%	COM	04963C209
—	CORINDUS VASCULAR ROBOTICS I	11,336,154	$21,085	9.7%	$1.31	—	COM	218730109
—	ACORDA THERAPEUTICS INC	773,090	$15,230	7.0%	$19.70	—	COM	00484M106
—	MAGELLAN HEALTH INC	98,700	$7,195	3.3%	$75.25	—	COM NEW	559079207
—	MERIDIAN BIOSCIENCE INC	123,300	$1,942	0.9%	$15.75	—	COM	589584101